Lighting the way to your finished ATMP
Top-tier manufacturing & Europe-wide distribution
Along with our expertise in the design and development of advanced therapies, we also support you with top-tier infrastructure and capabilities for producing ATMPs under the highest standards of quality and regulatory compliance. At Ideeea Therapeutics we have established a strategic alliance with Cellab CDMO for the manufacturing of ATMPs.
Choose Ideeea Therapeutics as your trusted partner for your cell and gene therapy development and manufacturing. Contact us today to learn more about our services and how we can help bring your therapy to market faster.
Strategic location in Andorra
EU batch release, delivering across Europe
Our facilities are fully equipped with cutting-edge technology for GMP manufacturing of allogeneic and autologous cell therapies
Lighting the way from your IND to the market
Streamline your journey from your IND (Investigational New Drug) to the market with a seamless CMC (Chemistry, Manufacturing and Controls) strategy, guided by a team with extensive expertise in advancing cell and gene therapies from early-stage discovery to successful commercialization. Our cell and gene therapy expertise covers a wide range of modalities, including autologous and allogeneic T-cell therapies (CAR-T, TCR, Treg), NK cells, iPSCs, MSCs, Extracellular Vesicles & Non-Cellular based therapies, and more.
With expertise in cell culture and both viral and non-viral genetic modification, we support a wide range of cell types, ensuring high-quality production for cell and gene therapy applications.
Our most relevant expertise includes:
Pluripotent and Stem Cells
- Mesenchymal Stem Cells (MSC): From different sources: Umbilical cord tissue, Adipose tissue and Bone Marrow with a highly scalable process that preserves the therapeutic qualities of the cells.
- Induced Pluripotent Stem Cells (iPSC): Reprogramming, expansion, and differentiation.
- Hematopoietic Stem Cells (HSC): Isolation, selection, expansion, and genetic modification. Extensive expertise in different expansion platforms and bioreactors for CD34+ stem cells.
- Stromal Vascular Fraction (SVF): Cell-rich fraction from adipose tissue for regenerative medicine applications.
Immune and Blood-Derived Cells
- T-Cells (including CAR-T and TCR-T): Engineered using viral and non-viral gene modification methods and expanded in different bioreactors.
- Regulatory T Cells (Tregs): Isolated from leukapheresis, umbilical cord blood, bone marrow, or thymus.
- Natural Killer (NK) Cells: Expansion and activation strategies for immunotherapy. Engineered using viral and non-viral gene modification methods.
- Leukocytes & Monocytes: Isolation and processing for personalized medicine.
Extracellular Vesicles & Non-Cellular Products
- Extracellular Vesicles (EVs) and Secretome: Scalable production using bioreactors.
- Platelet-Rich Plasma (PRP): Processing and quality-controlled manufacturing for therapeutic applications
Discover our scope of services at Cellab CDMO
Process Development
- GMP Bioprocess Design
- Scale-up
- Cryopreservation strategy
- Potency assays
- Donor or tissue selection
- Stability testing
GMP & GMP-Like Manufacturing
- Cell separation
- Gene editing
- Cell expansion and conditioning
- Fill and Finish
- Cryopreservation and cell banking
Quality Control
- Mycoplasma
- Morphology
- Cell count
- Viability
- Identity
- Purity
- Sterility
Logistics
- EU Batch Release
- GMP Bank
- Custom Clearance Service
- Transport Validation
- Shipping Worldwide